SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Gen-Probe
Incorporated (Nasdaq: GPRO) announced today that the Company will
present at three upcoming investor conferences:
- The Jefferies 2010 Global Life Sciences Conference in
New York at 11:30 a.m. Eastern Time (ET) on June 8.
- The 9th Annual Needham Healthcare Conference in New York at 4:40 p.m.
ET on June 9.
- The GARP Research and Securities Investor Conference in
Baltimore at 10:30 a.m. ET on June
10.
The presentations will be webcast live and may be accessed via
the investors section of Gen-Probe's website at www.gen-probe.com.
The webcasts will be available for 30 days following the event.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development,
manufacture and marketing of rapid, accurate and cost-effective
molecular diagnostic products and services that are used primarily
to diagnose human diseases, screen donated human blood, and ensure
transplant compatibility. Gen-Probe has approximately 27
years of expertise in nucleic acid testing, and received the 2004
National Medal of Technology, America's highest honor for
technological innovation, for developing NAT assays for blood
screening. Gen-Probe is headquartered in San Diego and employs approximately 1,300
people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations,
beliefs, plans, objectives, assumptions or future events or
performance are not historical facts and are forward-looking
statements. Forward-looking statements are not guarantees of
performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results, levels of activity,
performance or achievements to differ materially from those
expressed or implied. For information about risks and
uncertainties we face and a discussion of our financial statements
and footnotes, see documents we have filed with the SEC, including
our most recent Form 10-K, and all subsequent periodic filings made
with the SEC. We assume no obligation and expressly disclaim
any duty to update any forward-looking statement to reflect events
or circumstances after the date of this press release or to reflect
the occurrence of unanticipated events.
Contact:
|
|
|
|
Paula Izidoro
|
|
Investor Relations
|
|
858-410-8904
|
|
|
|
|
SOURCE Gen-Probe Incorporated